Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy
Clinical trial NCT04707547 · COMPLETED
Trial details
- NCT number
- NCT04707547
- Sponsor
- Taipei Medical University WanFang Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2020-07-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.